The psychology and neurobiology of addiction: An incentive-sensitization view

Addiction

Volumn 95, Issue 8, 2000, Pages

  Robinson, T E ^a   Berridge, K C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ARTICLE; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; HUMAN; LIMBIC CORTEX; NEUROBIOLOGY; PSYCHOLOGY; PSYCHOMOTOR ACTIVITY; REINFORCEMENT; RELAPSE; REWARD; SENSITIZATION; TREATMENT PLANNING;

EID: 0033842872     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1080/09652140050111681     Document Type: Article

References (217)

1. Nomenclature and classification of drug- and alcohol-related problems: A WHO memorandum
2. The neural basis of drug craving: An incentive-sensitization theory of addiction
3. Animal models of drug craving
4. New concepts in cocaine addiction: The dopamine depletion hypothesis
5. Drug addiction and drug abuse
6. Recent progress in research on the neurophysiological basis of morphine addiction
7. Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence
8. Opponent process model and psychostimulant addiction, Pharmacology
9. Drug abuse: Hedonic homeostatic dysregulation
10. Neurochemical explanations for addiction
11. Conditioning factors in drug tolerance
12. Conditioned opponent processes in the development of tolerance to psychoactive drugs
13. Current concepts of addiction
14. A psycho-motor stimulant theory of addiction
15. Relapse to heroin-seeking in rats under opioid maintenance: The effects of stress, heroin priming and withdrawal
16. Reinstatement of heroin self-administration habits: Morphine prompts and naltrexone discourages renewed responding after extinction
17. A range of research-based pharmacotherapies for addiction
18. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?
19. Remarks
20. Relationship between self-reported drug effects and their reinforcing effects: Studies with stimulant drugs
21. Effects of desipramine maintenance on cocaine self-administration by humans
22. Self-administration of cocaine by humans: A laboratory perspective
23. Assessment of abuse liability of stimulant drugs in humans: A methodological survey
24. Effects of pergolide on intravenous cocaine self-administration in men and women
25. Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans
26. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans
27. The reinforcing and subjective effects of morphine in post-addicts: A dose-response study
28. The mind of an addicted brain: Neural sensitization of wanting versus liking
29. Taste reactivity analysis of 6-hydroxydopamine-induced aphagia: Implications for arousal and anhedonia hypotheses of dopamine function
30. What psychological process mediates feeding evoked by electrical stimulation of the lateral hypothalamus?
31. Food reward: Brain substrates of wanting and liking
32. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
33. Stimulant-induced psychosis: An evaluation of animal models
34. Tolerance and sensitization to the behavioral effects of drugs
35. Differential effects of GABA(A) and GABA(B) agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2 J mice
36. Biphasic effects of ethanol on open-field activity: Sensitivity and tolerance in C57BL/6N and DBA/2N mice
37. Conditioned activation induced by ethanol: Role in sensitization and conditioned place preference
38. Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: Cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites
39. Duration of sensitization to the locomotor stimulant effects of ethanol in mice
40. The excitatory component of ethanol in mice: A chronic study
41. The excitatory effect of ethanol: Absence in rats, no tolerance and increased sensitivity in mice
42. Behavioral sensitization to ethanol: Genetics and the effects of stress
43. Enhancement of amphetamine- and cocaine-induced locomotor activity after chronic ethanol administration
44. Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: Possible role in behavioural sensitization
45. Effects of ventral striatal 6-OHDA lesions or amphetamine sensitization on ethanol consumption in the rat
46. A role for behavioral sensitization in uncontrolled ethanol intake
47. Chronic tolerance and sensitization to alcohol in sons of alcoholics
48. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization
49. The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dose-dependent
50. Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: A dose-effect study in rats
51. Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: Drugs as foreign/stressful stimuli
52. The time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats
53. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons
54. Stimulant drugs and stress: Factors influencing individual differences in the susceptibility to sensitization
55. Psychomotor stimulants
56. Behavioral and neuro-chemical sensitization following cocaine self-administration
57. Sensitization to the motor effects of contingent infusions of heroin but not of kappa agonist RU 51599
58. Behavioral sensitization is induced by intravenous self-administration of cocaine by rats
59. Differences in spontaneous and amphetamine-induced rotational behavior, and in sensitization to amphetamine, among Sprague-Dawley derived rats from different sources
60. Two dissociable components of behavioral sensitization following repeated amphetamine administration
61. Sensitization to cocaine stimulation in mice
62. Sex differences in sensitization to cocaine-induced rotation
63. Human and animal studies of cocaine: Implications for development of behavioral pathology
64. Behavioral sensitization: Characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats
65. Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration of D-amphetamine or restraint stress
66. Interchangeability of stress and amphetamine in sensitization
67. Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice
68. Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice
69. Genetic analysis of sensitization and tolerance to cocaine
70. Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration
71. Sensitization to the psychomotor stimulant effects of amphetamine: Modulation by associative learning
72. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants
73. Drug-environment interaction: Context dependency of cocaine-induced behavioral sensitization
74. Amphetamine-induced conditioned activity and sensitization: The role of habituation to the test context and the involvement of Pavlovian processes
75. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KC1 and electrical stimulation evoked striatal dopamine release in vitro
76. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens
77. Enhanced amphetamine- and K +-mediated dopamine release in rat striatum after repeated amphetamine: Differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles
78. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro
79. Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release
80. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment
81. Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine
82. Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli
83. A comparison of two behavioral measures of psychomotor activation following intravenous amphetamine or cocaine: Dose- and sensitization-dependent changes
84. Susceptibility to amphetamine-induced locomotor sensitization is modulated by environmental stimuli
85. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: Modulation by environmental novelty, Journal of Neuroscience
86. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons, Behavioural Brain Research
87. Sensitization and tolerance in psychostimulant self-administration Pharmacology
88. Preexposure sensitizes rats to the rewarding effects of cocaine
89. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine
90. Factors that predict individual vulnerability to amphetamine self-administration
91. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration
92. Predisposition to self-administer amphetamine: The contribution of response to novelty and prior exposure to the drug
93. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug
94. Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration
95. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys
96. Role of repeated exposure to morphine in determining its affective properties: Place and taste conditioning studies in rats
97. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine
98. Sensitization to the conditioned rewarding effects of cocaine: Pharmacological and temporal characteristics
99. Sensitization to the conditioned rewarding effects of morphine: Pharmacology and temporal characteristics
100. κ-opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine
101. Previous exposure to amphetamine increases incentive to obtain the drug: Long-lasting effects revealed by the progressive ratio schedule
102. Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule
103. Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization
104. Cocaine self-administration increases the incentive motivational properties of the drug in rats
105. Reinstatement of drug-seeking behavior following long-term extinction of cocaine and heroin self-administration: Possible role of behavioral sensitization
106. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization
107. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration
108. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine
109. Facilitation of sexual behaviors in the male rat associated with intra-VTA injections of opiates
110. Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization
111. Facilitation of sexual behavior and enhanced dopamine efflux in the nucleus accumbens of male rats after D-amphetamine-induced behavioral sensitization
112. Outpatient treatment of cocaine and crack addiction: A clinical perspective
113. Repeated d-amphetamine enhances stimulated mesoamygdaloid dopamine transmission
114. Enhanced dopamine efflux in the amygdala by a predictive, but not a non- predictive, stimulus: Facilitation by prior repeated D-amphetamine
115. Enhanced conditioned inhibition following repeated pretreatment with d-amphetamine
116. Enhanced appetitive conditioning following repeated pretreatment with d-amphetamine
117. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by past experience with (+)-amphetamine: A microdialysis study in freely moving rats
118. Neurobehavioural mechanisms of reward and motivation
119. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
120. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
121. Neuro-adaptations involved in amphetamine and cocaine addiction
122. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
123. Dopamine and food reward
124. Brain dopamine and reward
125. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system
126. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine
127. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine
128. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: Blockade by concurrent treatment with a glutamate antagonist
129. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine
130. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor
131. Amphetamine psychosis: Clinical variations of the syndrome
132. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis
133. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic upersensitivity - A clinical survey
134. Animal models of stimulant-induced psychosis
135. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain
136. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys
137. Enhanced response to repeated d-amphetamine challenge: Evidence for behavioral sensitization in humans
138. Progressive behavioral response to repeated d-amphetamine challenge: Further evidence for sensitization in humans
139. Behavioral sensitization in humans: Results of a parallel-group, double-blind study
140. Lack of evidence for context-dependent cocaine-induced sensitization in humans: Preliminary studies
141. Stimulant sensitization in humans
142. Stimulant sensitization in humans - Response
143. Selective sensitization to the psychosis-inducing effects of cocaine: A possible marker for addiction relapse vulnerability?
144. Acute effects of cocaine on human brain activity and emotion
145. Limbic activation during cue-induced cocaine craving
146. Activation of memory circuits during cue-elicited cocaine craving
147. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving
148. Regional brain metabolic activation during craving elicited by recall of previous drug experiences
149. Activation of reward circuitry in human opiate addicts
150. Cocaine decreases relative cerebral blood volume in humans: A dynamic susceptibility contrast magnetic resonance imaging study
151. Excitatory effects of dopamine released by impulse flow in the rat nucleus accumbens in vivo
152. Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo
153. Pleasure, pain, desire and dread: Hidden core processes of emotion
154. Neuroleptics and operant behavior: The anhedonia hypothesis
155. Drug craving and positive/negative hedonic brain substrates activated by addicting drugs
156. A brief history of the anhedonia hypothesis
157. Addicted: Why do people get hooked? Mounting evidence points to a powerful brain chemical called dopamine
158. Getting the brain's attention
159. Postcocaine anhedonia: An animal model of cocaine withdrawal
160. Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats
161. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
162. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration
163. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis
164. Blunting of reactivity of dopamine transmission to palatable food: A biochemical marker of anhedonia in the CMS model?
165. Relationship between subjective effects of cocaine and dopamine transporter occupancy
166. Transition from moderate to excessive drug intake: Change in hedonic set point
167. Dopamine functions in appetitive and defensive behaviours
168. Pimozide does not shift palatability: Separation of anhedonia from sensorimotor suppression by taste reactivity
169. Activity of dopamine neurons in the behaving primate
170. Predictive reward signal of dopamine neurons
171. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis
172. Haloperidol antagonism of cue-elicited cocaine craving
173. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers
174. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers
175. Effect of dopamine receptor antagonists on cocaine subjective effects: A naturalistic case study
176. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909
177. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of 'high'
178. How adaptive behavior is produced: A perceptual-motivation alternative to response reinforcement
179. A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes
180. Telling more than we can know: Verbal reports on mental processes
181. New challenges to the rationality assumption, Journal of lnstitutional and Theoretical Economics
182. A visceral account of addiction
183. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders
184. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli
185. The neuropsychiatry of chronic cocaine abuse
186. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms
187. Event-related potential evidence for frontal cortex effects of chronic cocaine dependence
188. Changes in brain glucose metabolism in cocaine dependence and withdrawal
189. Long-term frontal brain metabolic changes in cocaine abusers
190. Alcohol myopia
191. New pharmacotherapies for cocaine dependence ... revisited
192. A controlled trial of imipramine for the treatment of methamphetamine dependence
193. Imipramine treatment of cocaine abuse: Possible boundaries of efficacy
194. Relapse to cocaine abuse after initiating desipramine treatment
195. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens
196. Bupropion sustained release and smoking cessation
197. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
198. Evidence that the acute behavioral and electro-physiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism
199. Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain
200. Differential regulation of dopamine transporter after chronic self- administration of bupropion and nomifensine
201. Striatal dopaminergic abnormalities in human cocaine users
202. Expression and regulation of the human dopamine transporter in a neuronal cell line
203. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum
204. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex
205. Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain
206. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: A controlled study
207. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats
208. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal
209. Ibogaine effects on sweet preference and amphetamine induced locomotion: Implications for drug addiction
210. AMPA receptors and motivation for drug: Effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice
211. AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine- induced conditioned activity in mice